| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102067ASE0102067D0 (en) | 2001-06-11 | 2001-06-11 | Prevention of neovascularization of intervertebral discs and / or of tissues with local inflammation |
| PCT/SE2002/001115WO2002100387A1 (en) | 2001-06-11 | 2002-06-10 | Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102067ASE0102067D0 (en) | 2001-06-11 | 2001-06-11 | Prevention of neovascularization of intervertebral discs and / or of tissues with local inflammation |
| Publication Number | Publication Date |
|---|---|
| SE0102067D0true SE0102067D0 (en) | 2001-06-11 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0102067ASE0102067D0 (en) | 2001-06-11 | 2001-06-11 | Prevention of neovascularization of intervertebral discs and / or of tissues with local inflammation |
| Country | Link |
|---|---|
| SE (1) | SE0102067D0 (en) |
| WO (1) | WO2002100387A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003232081B2 (en)* | 2002-07-03 | 2009-02-05 | Brandeis University | Central airway administration for systemic delivery of therapeutics |
| MXPA05012275A (en) | 2003-05-13 | 2006-02-10 | Depuy Spine Inc | A method of treating degenerative disc disease. |
| US7429378B2 (en) | 2003-05-13 | 2008-09-30 | Depuy Spine, Inc. | Transdiscal administration of high affinity anti-MMP inhibitors |
| US8273347B2 (en) | 2003-05-13 | 2012-09-25 | Depuy Spine, Inc. | Autologous treatment of degenerated disc with cells |
| US7553827B2 (en) | 2003-08-13 | 2009-06-30 | Depuy Spine, Inc. | Transdiscal administration of cycline compounds |
| US7344716B2 (en) | 2003-05-13 | 2008-03-18 | Depuy Spine, Inc. | Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
| US8361467B2 (en) | 2003-07-30 | 2013-01-29 | Depuy Spine, Inc. | Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints |
| US8895540B2 (en) | 2003-11-26 | 2014-11-25 | DePuy Synthes Products, LLC | Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
| ITRM20030601A1 (en) | 2003-12-24 | 2005-06-25 | Lay Line Genomics Spa | METHOD FOR THE HUMANIZATION OF HUMANIZED ANTIBODIES AND ANTIBODIES WITH IT OBTAINED. |
| US7217425B2 (en) | 2004-07-23 | 2007-05-15 | Depuy Spine, Inc. | Autologous coatings for implants |
| US8715733B2 (en) | 2004-07-23 | 2014-05-06 | DePuy Synthes Products, LLC | Enhanced adipose tissue |
| US7399742B2 (en) | 2004-07-23 | 2008-07-15 | Depuy Spine, Inc. | Anti-osteolytic therapy involving adiponectin |
| ITRM20050290A1 (en) | 2005-06-07 | 2006-12-08 | Lay Line Genomics Spa | USE OF MOLECULES ABLE TO INHIBIT THE BOND BETWEEN NGF AND ITS TRKA RECEPTOR AS AN EXTENDED EFFECT ANALGESICS. |
| US8986696B2 (en) | 2007-12-21 | 2015-03-24 | Depuy Mitek, Inc. | Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints |
| AU2009329811B2 (en)* | 2008-12-22 | 2016-02-25 | The University Of Melbourne | Pain treatment |
| ES2533952T3 (en) | 2009-02-09 | 2015-04-16 | Morphosys Ag | Production of oligoclonal mixtures of immunoglobulins in individual cells |
| EP2481751A1 (en)* | 2011-01-26 | 2012-08-01 | PharmaSurgics in Sweden AB | Human lactoferrin derived peptides |
| CN110613837A (en)* | 2019-10-24 | 2019-12-27 | 内蒙古医科大学第二附属医院 | Application of TGF-beta in preparation of medicine for preventing or treating lumbar disc herniation |
| Publication number | Publication date |
|---|---|
| WO2002100387A1 (en) | 2002-12-19 |
| Publication | Publication Date | Title |
|---|---|---|
| SE0102067D0 (en) | Prevention of neovascularization of intervertebral discs and / or of tissues with local inflammation | |
| MXPA05008617A (en) | Uses of anti-insulin-like growth factor i receptor antibodies. | |
| RS52867B (en) | Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis | |
| AU2003301190A1 (en) | Administration of capsaicinoids | |
| WO2006119958A3 (en) | Use of flibanserin in the treatment of chronic pain | |
| CA2404387A1 (en) | Theanine compositions for promoting sleep | |
| EA201170018A1 (en) | Razagilin to change the flow of Parkinson's disease | |
| ATE454140T1 (en) | DOPAMINE AGONIST COMBINATION THERAPY WITH SEDATIVES TO IMPROVE SLEEP QUALITY | |
| WO2006058140A3 (en) | Capsaicinoid gel formulation and uses thereof | |
| TW200640486A (en) | Composition | |
| DE60321929D1 (en) | PHARMACEUTICAL COMPOSITIONS WITH DEXTROMETHORPHANE AND CHINIDINE FOR THE TREATMENT OF NEUROLOGICAL ILLNESSES | |
| BRPI0410721A (en) | foamable pharmaceutical compositions and methods for treating a disorder | |
| WO2003073981A3 (en) | Novel of cytokine inhibitors | |
| AU4741001A (en) | Viscoelastics for use in middle ear surgery | |
| WO2005037323A3 (en) | Use of gro to treat or prevent inflammation | |
| IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
| MX2009012109A (en) | Anti-insomnia compositions and methods. | |
| WO2005046593A3 (en) | Methods and compositions using thalidomide for the treatment and management of cancers and other diseases. | |
| WO2005081742A3 (en) | Testosterone oral dosage formulations and associated methods | |
| TW200635598A (en) | Oral suspension comprising meloxicam | |
| WO2004043378A3 (en) | Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| WO2001089536A3 (en) | Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders | |
| MXPA02006511A (en) | Complex comprising ocif and polysaccharide. | |
| SE0101256D0 (en) | Treatment of low back pain |